SCHEMBL18764366

SCHEMBL18764366

CCCc1cnc(-c2ccccc2)nc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.43
ALDH1A1 P00352 6/20 0.43
MAPT P10636 3/20 0.43
LMNA P02545 3/20 0.43
MAPK1 P28482 1/20 0.43
ATM Q13315 1/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
TP53 P04637 1/20 0.43
TKT P29401 1/20 0.42
KDM4E B2RXH2 1/20 0.42
KMT2A Q03164 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
RXRA P19793 1/20 0.41
NR4A2 P43354 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4D Q08499 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11982021 0.86 SMN1; SMN2 (0.49) SMN1; SMN2ALDH1A1MAPTLMNAMAPK1
SCHEMBL11014329 0.85 RAB9A (0.44) SMN1; SMN2ALDH1A1MAPTNPC1RAB9A
SCHEMBL28035552 0.85 TKT (0.41) SMN1; SMN2ALDH1A1MAPTLMNAMAPK1
SCHEMBL18764349 0.84 RAB9A (0.43) SMN1; SMN2ALDH1A1MAPTLMNAATM
SCHEMBL10490466 0.81 KMT2A (0.42) SMN1; SMN2ALDH1A1MAPTLMNAMAPK1
SCHEMBL120535 0.81 TKT (0.46) SMN1; SMN2ALDH1A1MAPTLMNAMAPK1
SCHEMBL11018925 0.80 RAB9A (0.57) SMN1; SMN2ALDH1A1MAPTATMNPC1
SCHEMBL12775821 0.79 KMT2A (0.41) SMN1; SMN2ALDH1A1MAPTLMNAMAPK1
SCHEMBL11017065 0.78 RAB9A (0.48) SMN1; SMN2ALDH1A1MAPTLMNAMAPK1
SCHEMBL6850660 0.78 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1MAPTLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3365329-A1 NURR1:RXR ACTIVATING COMPOUNDS FOR SIMULTANEOUS TREATMENT OF SYMPTOMS AND PATHOLOGY OF PARKINSON'S DISEASE Vassilatis, Demetrios K. (GR) 2018-08-29 EP disclosed
WO-2017068070-A1 NURR1:RXR ACTIVATING COMPOUNDS FOR SIMULTANEOUS TREATMENT OF SYMPTOMS AND PATHOLOGY OF PARKINSON'S DISEASE VASSILATIS DEMETRIOS K (GR) 2017-04-27 WO disclosed